Tumour markers testing

GENETIC3 trials

Sponsors

European Organisation for Research and Treatment of Cancer - EORTC

Conditions

Advanced Colorectal CancerAny Stage of Any Thymic MalignancyAny Stage of Lung Cancer (Any Histotype)Any Stage of Malignant Pleural MesotheliomaBrain NeoplasmsColorectal Cancer

Unknown Phase

Screening Platform for Clinical Trials in Advanced Colorectal Cancer

CompletedNCT01723969

European Organisation for Research and Treatment of Cancer - EORTCAdvanced Colorectal Cancer, Colorectal Cancer

Start: 2013-09-30End: 2020-03-10Updated: 2022-07-07

SPECTAlung: Screening Patients With Thoracic Tumors for Efficient Clinical Trial Access

CompletedNCT02214134

European Organisation for Research and Treatment of Cancer - EORTCAny Stage of Any Thymic Malignancy, Any Stage of Lung Cancer (Any Histotype), Any Stage of Malignant Pleural Mesothelioma

Start: 2015-05-22End: 2021-05-12Updated: 2025-08-17

SPECTAbrain: Screening Patients With Brain Tumors for Efficient Clinical Trial Access

WithdrawnNCT02307604

European Organisation for Research and Treatment of Cancer - EORTCBrain Neoplasms

Start: 2016-05-31End: 2019-01-31Updated: 2019-06-24

Related Papers

Abstract 1604: IMI CANCER-ID: Validation of novel blood-based biomarker technologies in clinical settings

Cancer Research2015-08-01